Observational Study for Advanced Prostate Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to learn more about advanced prostate cancer that has spread beyond its original site. Researchers collect blood, urine, and tissue samples, along with information about treatment, diet, and quality of life, to improve future patient outcomes. Men diagnosed with advanced prostate cancer who are about to start a new treatment are ideal participants.
As a Phase 3 trial, this study represents the final step before FDA approval, offering participants the opportunity to contribute to a potentially groundbreaking treatment.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Why are researchers excited about this trial?
Researchers are excited about the Longitudinal Advanced Prostate Cancer Cohort (LAPCC) trial because it takes a fresh approach by not testing a specific drug but by closely observing patients with advanced prostate cancer. Unlike traditional treatments like hormone therapy, chemotherapy, or surgery, this trial focuses on gathering detailed data from blood and urine samples, surveys, and medical records over time. The goal is to uncover patterns and insights that could lead to more personalized and effective treatment strategies in the future. This approach could significantly enhance our understanding of the disease and improve patient outcomes by tailoring treatments to individual needs.
Who Is on the Research Team?
Amir Goldkorn, MD
Principal Investigator
University of Southern California
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Observational
Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Non-Interventional Study
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.